Loading…
for educational and safety purposes
Buprenorphine and Methadone both come up in the same conversations; they overlap on Mu-opioid receptor and Pain. Buprenorphine: Buprenorphine is a semisynthetic opioid that acts as a partial agonist at the mu-opioid receptor. Methadone: Methadone is a synthetic opioid medication that acts mainly as an agonist at the mu-opioid receptor, with additional activity as an antagonist at the NMDA glutamate receptor.
Buprenorphine is a semisynthetic opioid that acts as a partial agonist at the mu-opioid receptor. It is widely used to treat opioid use disorder and is also used for acute and chronic pain. First developed in the 1960s from the poppy alkaloid thebaine, it is often combined with naloxone in formulations intended to discourage misuse.
Methadone is a synthetic opioid medication that acts mainly as an agonist at the mu-opioid receptor, with additional activity as an antagonist at the NMDA glutamate receptor. It is used both to treat opioid use disorder, where long-acting daily doses prevent withdrawal and reduce cravings, and to manage chronic and cancer pain. First synthesized in Germany in the late 1930s, methadone is distinguished among opioids by its long and variable duration of action, and it is listed as an essential medicine by the World Health Organization.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
partial agonist
agonist
antagonist
antagonist
partial agonist
blocks
antagonist
inhibits reuptake
inhibits reuptake
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.